Table 3:

Peak plasma concentration levels to be expected after therapeutic doses of dabigatran, rivaroxaban, apixaban or edoxaban [13].

Anticoagulant drug	Peak plasma concentration (ng/mL)
	Nonvalvular atrial fibrillation	Venous thromboembolism
Dabigatran	117–275	117–275
Rivaroxaban	184–343	189–419
Apixaban	91–321	59–302
Edoxaban	125–245	149–317